Lucid Diagnostics Inc. (NASDAQ: LUCD) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT LUCID DIAGNOSTICS INC.

Lucid Diagnostics Inc. (NASDAQ: LUCD)
Listen to this Section


$0.99
-0.0270 ( -2.65% ) 390.9K

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Market Data


Open $0.99
Previous Close $1.02
Volume 390.9K
Market Cap $191.71M
Day Range $0.98 - $1.03
52 Week Range $0.90 - $1.63
Shares Outstanding 190.76M
Change % -2.65%
Net Change ▼ -0.0270
Insider Ownership -0.18%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
IPO Year2021
CountryUnited States
UnderwriterCantor Fitzgerald, Canaccord Genuity, BTIG, Needham & Co., more

Insider Ownership Transactions

Total Amount Purchased: -8,971,525.00

Date Type Amount Purchased Purchaser
2025-08-22 Buy 100000.00 Matheis Dennis
2025-05-22 Buy 187098.00 Matheis Dennis
2024-05-09 Sale -241500.00 Matheis Dennis
2024-05-08 Sale -400000.00 O'Neil Shaun
2024-05-08 Sale -400000.00 Aklog Lishan
2024-05-08 Sale -400000.00 MCGRATH DENNIS M
2024-05-08 Sale -400000.00 Gordon Michael Adam
2024-02-23 Sale -150000.00 Lapidus Stanley
2024-02-23 Sale -150000.00 SOKOLOV JACQUE J
2024-02-23 Sale -150000.00 White Debra

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Jun 18, 2025

Latest News


× Before browsing our site, please accept our cookies policy